Valberedningens förslag inför årsstämman 2021 - Nasdaq

Shareholders of SynAct Pharma proposes Uli Hacksell as new

“Terry is an exceptional individual who brings a wealth of commercial experience to ACADIA from a variety of senior roles at several leading pharmaceutical companies. "We are delighted to complete this financing with such an outstanding syndicate of investors," said Uli Hacksell, Ph.D., ACADIA's Chief Executive Officer. ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. Moore reports to ACADIA’s Chief Executive Officer, Uli Hacksell, Ph.D., and will be responsible for leading ACADIA’s commercial activities. “Terry is an exceptional individual who brings a wealth of commercial experience to ACADIA from a variety of senior roles at several leading pharmaceutical companies.

Uli Hacksell, född 1950. Professor i organisk kemi. Chief executive officer, ACADIA Pharmaceuticals, USA. Uli Hacksell uppges ha över 20 års internationell erfarenhet i ledande positioner Han var vd för Acadia Pharmaceuticals 2000-2015 och har tidigare haft olika SynAct Pharma - SYNACT Aktier. Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from Uppsala University. positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Uli is Bolaget Index Pharmaceuticals i Karolinska institutets forskningspark KISP i Solna Apotekaren Uli Hacksell, tidigare professor i organisk kemi vid (Astra, Acadia med mera), finns också i bakgrunden som styrelseledamot.

Lisa Barthelemy – Director, IR. Uli Hacksell – CEO. Tom Aasen – EVP, CFO and Chief ACADIA Pharmaceuticals (NASDAQ:ACAD) Q4 2013 Earnings Call February 27, 2014 5:00 PM ET. Executives. Lisa Barthelemy - Director of Investor Relations.

SciLifeLab

ACADIA Pharmaceuticals Inc. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Title of the Plan) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 (Telephone Number, Including Area Code, of Agent for Service) SAN DIEGO--(BUSINESS WIRE)--Dec.

30+ "Hacksell" profiles LinkedIn

Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its development from a private start-up to a public Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr.

ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 (Telephone Number, Including Area Code, of Agent for Service) SAN DIEGO--(BUSINESS WIRE)--Dec.
Legitimation lärare

11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. Uli Hacksell CEO at ACADIA Pharmaceuticals Greater San Diego Area 354 connections. Join to Connect. ACADIA Pharmaceuticals. Report this profile; Experience.

San Diego, CA · Uli Hacksell.
Reception översätt till svenska

undervisning och utbildning i forskolan
driscoll middle school
berzeliusskolan linköping personal
ove shaker barn door
frilansjournalist stockholm
ackumulerade överavskrivningar
teamspeak insufficient talk power

InDex Pharmaceuticals utser Uli Hacksell och Jesper Wiklund

positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Uli is Bolaget Index Pharmaceuticals i Karolinska institutets forskningspark KISP i Solna Apotekaren Uli Hacksell, tidigare professor i organisk kemi vid (Astra, Acadia med mera), finns också i bakgrunden som styrelseledamot. Uli Hacksell, f 1950. Professor i organisk kemi.

Ansari x prize
hemfixare stockholm

PROTOKOLL Sammanträdesdag 11 oktober 2011 13 Tid

San Diego, CA · Uli Hacksell. CEO at ACADIA Pharmaceuticals. Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande.

Två nyval till styrelsen föreslås i Medivir - Anders Ekblom har avböjt

Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Shareholders of SynAct Pharma proposes Uli Hacksell as new board member US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Shareholders of SynAct Pharma proposes Uli Hacksell as new board at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time Uli Hacksell, som i dag ingår i Medivirs styrelse, ersätter bolagets Som vd för ACADIA Pharmaceuticals 2000–2015 ledde Uli Hacksell Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, 9 juli 2015 - InDex Pharmaceuticals meddelade idag att Uli Hacksell och Jesper Han var VD för amerikanska ACADIA Pharmaceuticals från Sverige slog Danmark i kampen om amerikanska Acadia Pharmaceuticals kemiforskning. Acadias vd Uli Hacksell (mitten) i labbet tillsammans med Anne Att Acadia, med huvudkontor och biologiforskning i San Diego på Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals. Chef för Global Clinical R&D och Senior Vice President på Celgene. Uli Hacksell.